(Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) Versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC

PHASE2CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

Not specified

Primary Completion Date

February 28, 1994

Conditions
HIV Infections
Interventions
DRUG

Zidovudine

DRUG

Zalcitabine

Trial Locations (25)

11220

Sunset Park Health Ctr - Lutheran Med Ctr, Brooklyn

12203

Albany Med College / AIDS Treatment Ctr, Albany

19146

Graduate Hosp, Philadelphia

20007

Georgetown Univ Med Ctr, Washington D.C.

27103

Bowman Gray School of Medicine / North Carolina Baptist Hosp, Winston-Salem

30308

AIDS Research Consortium of Atlanta, Atlanta

33125

Med Service, Miami

33308

Ctr for Special Immunology, Fort Lauderdale

33901

Comprehensive Clinic / Dr Robert Schwartz, Fort Myers

44106

Univ Hosp of Cleveland / Case Western Reserve Univ, Cleveland

48202

Henry Ford Hosp, Detroit

60611

Northwestern Univ Med School, Chicago

60612

Rush Presbyterian - Saint Luke's Med Ctr, Chicago

75219

N Texas Ctr for AIDS & Clin Rsch, Dallas

77030

Baylor College of Medicine, Houston

77550

Univ TX Galveston Med Branch, Galveston

90027

Kaiser Permanente Med Ctr, Los Angeles

90710

Kaiser Foundation Hosp, Harbor City

94114

Davies Med Ctr, San Francisco

94115

Mount Zion Med Ctr, San Francisco

94121

San Francisco Veterans Administration Med Ctr, San Francisco

95128

Santa Clara Valley Med Ctr, San Jose

95817

UCD Med Ctr, Sacramento

02111

New England Med Ctr, Boston

07102

Saint Michael's Med Ctr, Newark

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH